Kobayashi Pharmaceutical Co Financials

Kobayashi Pharmaceutical Stock Summary

Kobayashi Pharmaceutical competes with 51Talk Online, Deluxe, Bank of New York, Ameriprise Financial, and Stagwell. Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan. Kobayashi Pharmaceutical operates under Household Personal Products classification in the United States and is traded on OTC Exchange. It employs 3451 people.

Kobayashi Pharmaceutical Key Financial Ratios

There are many critical financial ratios that Kobayashi Pharmaceutical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Kobayashi Pharmaceutical reports annually and quarterly.

Kobayashi Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kobayashi Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Kobayashi Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kobayashi Pharmaceutical competition to find correlations between indicators driving Kobayashi Pharmaceutical's intrinsic value. More Info.Kobayashi Pharmaceutical Co is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about  0.65  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Kobayashi Pharmaceutical Co is roughly  1.53 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kobayashi Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Kobayashi Pharmaceutical Market Pulse

Along with financial statement analysis, the daily predictive indicators of Kobayashi Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kobayashi Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kobayashi Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Kobayashi Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kobayashi Pharmaceutical's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.